应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FLGT Fulgent Genetics Inc.
休市中 05-31 16:00:00 EDT
20.65
-0.70
-3.28%
盘后
20.65
+0.00
0.00%
16:20 EDT
最高
21.65
最低
20.60
成交量
17.55万
今开
21.36
昨收
21.35
日振幅
4.92%
总市值
6.18亿
流通市值
4.09亿
总股本
2,992万
成交额
364.88万
换手率
0.89%
流通股本
1,980万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Fulgent Genetics Inc 预计每股亏损 32 美分 - 财报前瞻
Reuters · 05-01
Fulgent Genetics Inc 预计每股亏损 32 美分 - 财报前瞻
Fulgent Genetics, Inc.盘中异动 大幅拉升5.02%报21.11美元
自选股智能写手 · 04-30
Fulgent Genetics, Inc.盘中异动 大幅拉升5.02%报21.11美元
美国研究综述-Arrivent 生物制药公司、弗格森公司、目标公司
Reuters · 03-06
美国研究综述-Arrivent 生物制药公司、弗格森公司、目标公司
加载更多
公司概况
公司名称:
Fulgent Genetics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司,拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务,旨在为医生和患者提供临床可操作的诊断信息,以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物,该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征,或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。
发行价格:
--
{"stockData":{"symbol":"FLGT","market":"US","secType":"STK","nameCN":"Fulgent Genetics Inc.","latestPrice":20.65,"timestamp":1717185600000,"preClose":21.35,"halted":0,"volume":175532,"hourTrading":{"tag":"盘后","latestPrice":20.65,"preClose":20.65,"latestTime":"16:20 EDT","volume":8452,"amount":174534.4646,"timestamp":1717186800643},"delay":0,"floatShares":19800664,"shares":29924288,"eps":-5.560807,"marketStatus":"休市中","marketStatusCode":7,"change":-0.7,"latestTime":"05-31 16:00:00 EDT","open":21.36,"high":21.65,"low":20.6,"amount":3648766.1308,"amplitude":0.04918,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.560807,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1717401600000},"adr":0,"listingDate":1475121600000,"adjPreClose":21.35,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":20.65,"preClose":20.65,"latestTime":"16:20 EDT","volume":8452,"amount":174534.4646,"timestamp":1717186800643},"volumeRatio":1.3964537325881208},"requestUrl":"/m/hq/s/FLGT","defaultTab":"news","newsList":[{"id":"2432557076","title":"Fulgent Genetics Inc 预计每股亏损 32 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432557076","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432557076?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:54","pubTimestamp":1714571688,"startTime":"0","endTime":"0","summary":" * Fulgent Genetics Inc 将于5月3日公布截至2024年3月31日的财报,预计该公司的季度收入将出现下降。* 根据LSEG的数据,3位分析师的平均预期是,这家总部位于加利福尼亚州艾尔蒙特的公司的营收将从去年同期的6617万美元下降1.2%,至6536.3万美元。* LSEG分析师对Fulgent Genetics公司的平均预期是每股亏损32美分。* 华尔街对 Fulgent Genetics Inc 的 12 个月目标价中位数为 25.00 美元,高于其上次收盘价 20.35 美元。5月1日 - 以前季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431970618","title":"Fulgent Genetics, Inc.盘中异动 大幅拉升5.02%报21.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431970618","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431970618?lang=zh_cn&edition=full","pubTime":"2024-04-30 00:09","pubTimestamp":1714406988,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日00时09分,Fulgent Genetics, Inc.股票出现波动,股价快速上涨5.02%。Fulgent Genetics, Inc.股票所在的生命科学行业中,整体涨幅为1.20%。其相关个股中,Endra Life Sciences Inc.、23Andme Holding Co.、Neogenomics, Inc.涨幅较大,Applied Dna Sciences, Inc.、Ispecimen Inc.、奎斯特诊疗较为活跃,换手率分别为1.61%、1.09%、0.88%,振幅较大的相关个股有Endra Life Sciences Inc.、23Andme Holding Co.、Xwell, Inc.,振幅分别为22.69%、10.77%、10.47%。Fulgent Genetics, Inc.公司简介:Fulgent Genetics Inc 是一家专注于基因检测的技术公司,为医生提供临床可操作的诊断信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430000948861ea232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240430000948861ea232&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417239460","title":"美国研究综述-Arrivent 生物制药公司、弗格森公司、目标公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2417239460","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417239460?lang=zh_cn&edition=full","pubTime":"2024-03-06 14:48","pubTimestamp":1709707680,"startTime":"0","endTime":"0","summary":" 路透社3月6日 - 华尔街证券分析师周三调整了对 Arrivent Biopharma、Ferguson 和 Target 等几家美国上市公司的评级和目标价。要闻 * Arrivent Biopharma Inc :杰富瑞给予买入评级 * 弗格森 :杰富瑞将目标价从 222 美元上调至 244 美元 * Target Corp :汇丰银行将其评级从 \"持有 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulgentgenetics.com","stockEarnings":[{"period":"1week","weight":-0.0346},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.1114},{"period":"6month","weight":-0.2483},{"period":"1year","weight":-0.4926},{"period":"ytd","weight":-0.2857}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.054},{"period":"3month","weight":0.0283},{"period":"6month","weight":0.1487},{"period":"1year","weight":0.2502},{"period":"ytd","weight":0.1095}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司,拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务,旨在为医生和患者提供临床可操作的诊断信息,以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物,该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征,或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.147937},{"month":2,"riseRate":0.375,"avgChangeRate":-0.004993},{"month":3,"riseRate":0.25,"avgChangeRate":-0.035738},{"month":4,"riseRate":0.25,"avgChangeRate":0.019298},{"month":5,"riseRate":0.375,"avgChangeRate":-0.024642},{"month":6,"riseRate":0.714286,"avgChangeRate":0.052729},{"month":7,"riseRate":0.714286,"avgChangeRate":0.132054},{"month":8,"riseRate":0.285714,"avgChangeRate":0.018581},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.032387},{"month":10,"riseRate":0.125,"avgChangeRate":-0.08803},{"month":11,"riseRate":0.625,"avgChangeRate":0.099665},{"month":12,"riseRate":0.75,"avgChangeRate":0.061218}],"exchange":"NASDAQ","name":"Fulgent Genetics Inc.","nameEN":"Fulgent Genetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulgent Genetics Inc.,FLGT,Fulgent Genetics Inc.股票,Fulgent Genetics Inc.股票老虎,Fulgent Genetics Inc.股票老虎国际,Fulgent Genetics Inc.行情,Fulgent Genetics Inc.股票行情,Fulgent Genetics Inc.股价,Fulgent Genetics Inc.股市,Fulgent Genetics Inc.股票价格,Fulgent Genetics Inc.股票交易,Fulgent Genetics Inc.股票购买,Fulgent Genetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}